March 7, 2017 / 5:52 PM / 4 months ago

BRIEF-Onxeo FY net loss widens to 22.7 million euros

1 Min Read

March 7 (Reuters) - Onxeo SA:

* FY revenue EUR 4.4 million ($4.65 million) versus EUR 3.5 million year ago

* FY operating loss of EUR 23.2 million versus loss of EUR 22.4 million year ago

* FY net loss EUR 22.7 million versus loss of EUR 19.4 million year ago

* Cash and cash equivalents of EUR 29.2 million at December 31, 2016

* Enrolment for the phase III Livatag study in advanced primary liver cancer completed on schedule to deliver preliminary results mid-2017 Further company coverage: ($1 = 0.9454 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below